Overview of Glucagon-like Peptide-1 Receptor Agonists

Academic Article


  • Type 2 diabetes mellitus is an increasingly prevalent disease in the United States and globally. Multiple pharmacologic therapies are typically required over time to achieve and maintain target blood glucose levels. When first-line oral medications such as metformin (Glucophage) are not effective in achieving desired glycosylated hemoglobin (HbA1C) levels, glucagon-like peptide-1 receptor agonists may be used. This article provides an overview of this class of agents and provides implications for home healthcare clinicians.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Steadman L; Grant JS; Graven LJ
  • Start Page

  • 534
  • End Page

  • 544
  • Volume

  • 33
  • Issue

  • 10